Show simple item record

dc.contributor.authorJabbarzadegan, M
dc.contributor.authorRajayi, H
dc.contributor.authorJahromi, MAM
dc.contributor.authorYeganeh, H
dc.contributor.authorYousefi, M
dc.contributor.authorHassan, ZM
dc.contributor.authorMajidi, J
dc.date.accessioned2018-08-26T07:19:33Z
dc.date.available2018-08-26T07:19:33Z
dc.date.issued2017
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/45644
dc.description.abstractTo concentrate a potent anticancer drug (Arteether) in tumor microenvironment, we encapsulated it in biodegradable and pH sensitive polyurethane (PU) nanomicelles (NMs). The nanocomplex was characterized by Fourier transform infrared (FTIR), dynamic light scattering (DLS). The loading capacity and release profile in pH of 5.4 and 7.4 were considered. The cytotoxicity effect was evaluated in vitro and in vivo settings. The level of IFN- and IL-4 cytokines of mice splenocytes were assessed by enzyme-linked immunosorbent assay (ELISA). The nanocomplex showed negative zeta charge of -26.2mV, size of 42.30nm and high loading capacity (92%). Release profile showed a faster rate of drug liberation at pH 5.4 as compared to that of pH 7.4. It indicated significant inhibitory effect on the growth of 4T1 cell line and increased IFN- level.
dc.language.isoEnglish
dc.relation.ispartofARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY
dc.subjectCancer therapy
dc.subjectimmunostimulator
dc.subjectnanocarrier
dc.subject4T1
dc.titleApplication of arteether-loaded polyurethane nanomicelles to induce immune response in breast cancer model
dc.typeArticle
dc.citation.volume45
dc.citation.issue4
dc.citation.spage808
dc.citation.epage816
dc.citation.indexWeb of science
dc.identifier.DOIhttps://doi.org/10.1080/21691401.2016.1178131


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record